Global Post Operative Pain Management Market

Post Operative Pain Management Comprehensive Study by Route of Administration (Injectable Postoperative Pain Management, Oral Postoperative Pain Management, Transdermal Postoperative Pain Management, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Others), Treatment (Opioid Treatment, Non- Opioid Treatment) Players and Region - Global Market Outlook to 2027

Post Operative Pain Management Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Post Operative Pain Management?
Postoperative ache administration is worried with the strategies or approaches to decrease the ache to the sufferers after surgery. Due to this pain, sufferers lengthen remain in hospitals and bear bodily and psychological stress. Postoperative ache administration gives a remedy that is aimed at comforting sufferers after surgery. Various capsules are administered such as – Opioids, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Anaesthetics, Cyclooxygenase (COX) inhibitors, etc. These capsules can be administered via more than a few routes such as – oral, injection, transdermal and topical. All surgical procedures are related with some variety of postoperative pain.

The market study is broken down and major geographies with country level break-up.

The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing towards the production technologies, efficiency enhancement and product life. There is various growth opportunity in this market which is captured by leading players via tracking the ongoing process enhancement and huge invest in market growth strategies. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global Post Operative Pain Management market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Teva Pharmaceutical Industries Ltd., (Israel), Novartis AG, (Switzerland), Allergan plc, (Ireland), Mylan N.V., (United States), Pfizer Inc., (United States), Purdue Pharma L.P, (United States), Janssen Pharmaceuticals, Inc., (Belgium), Endo International plc (Ireland), Pacira Pharmaceuticals Inc., (United States) and GlaxoSmithKline Plc. (United Kingdom) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Egalet Corporation (United States).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Post Operative Pain Management market by Type, Application and Region.

On the basis of geography, the market of Post Operative Pain Management has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Route of Administration, the sub-segment i.e. Injectable Postoperative Pain Management will boost the Post Operative Pain Management market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Hospital Pharmacies will boost the Post Operative Pain Management market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Treatment , the sub-segment i.e. Opioid Treatment will boost the Post Operative Pain Management market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

In 2020, Pfizer Inc. announced that it has completed the transaction to spin off its Upjohn Business and combine it with Mylan N.V. to form Viatris Inc. Pfizer Chairman and Chief Executive Officer Dr. Albert Bourla said, “We are proud to have completed the combination of Upjohn and Mylan to create Viatris and pleased to have delivered value to our shareholders through this transaction. I want to express my gratitude to our Upjohn colleagues for their dedication in helping us achieve this milestone.


Market Trend
  • Rise in demand for Opioid Analgesics
  • Investments in Product Development for New non-abuse Opioids

Market Drivers
  • Growing Demand for Novel non-opioid Analgesics in Postoperative Pain Management Therapy
  • Increasing Prevalence of Chronic Disease

Opportunities
  • Increasing Healthcare Expenditure
  • Advancement in Technology

Restraints
  • Rising Cost Burden of Pain Management on Reimbursement Providers
  • Adverse Side Effects Associated
  • Limited Availability of Postoperative Pain Management Drugs


Key Target Audience
Manufacturers of Footwear, Distributors and Suppliers of Footwear, Raw Material Suppliers, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Route of Administration
  • Injectable Postoperative Pain Management
  • Oral Postoperative Pain Management
  • Transdermal Postoperative Pain Management
  • Others

By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Others

By Treatment
  • Opioid Treatment
  • Non- Opioid Treatment

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Demand for Novel non-opioid Analgesics in Postoperative Pain Management Therapy
      • 3.2.2. Increasing Prevalence of Chronic Disease
    • 3.3. Market Trends
      • 3.3.1. Rise in demand for Opioid Analgesics
      • 3.3.2. Investments in Product Development for New non-abuse Opioids
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Post Operative Pain Management, by Route of Administration, Distribution Channel, Treatment and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Post Operative Pain Management (Value)
      • 5.2.1. Global Post Operative Pain Management by: Route of Administration (Value)
        • 5.2.1.1. Injectable Postoperative Pain Management
        • 5.2.1.2. Oral Postoperative Pain Management
        • 5.2.1.3. Transdermal Postoperative Pain Management
        • 5.2.1.4. Others
      • 5.2.2. Global Post Operative Pain Management by: Distribution Channel (Value)
        • 5.2.2.1. Hospital Pharmacies
        • 5.2.2.2. Retail Pharmacies
        • 5.2.2.3. Drug Stores
        • 5.2.2.4. Others
      • 5.2.3. Global Post Operative Pain Management Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Post Operative Pain Management: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Teva Pharmaceutical Industries Ltd., (Israel)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Novartis AG, (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Allergan plc, (Ireland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Mylan N.V., (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Pfizer Inc., (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Purdue Pharma L.P, (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Janssen Pharmaceuticals, Inc., (Belgium)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Endo International plc (Ireland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Pacira Pharmaceuticals Inc., (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. GlaxoSmithKline Plc. (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Post Operative Pain Management Sale, by Route of Administration, Distribution Channel, Treatment and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Post Operative Pain Management (Value)
      • 7.2.1. Global Post Operative Pain Management by: Route of Administration (Value)
        • 7.2.1.1. Injectable Postoperative Pain Management
        • 7.2.1.2. Oral Postoperative Pain Management
        • 7.2.1.3. Transdermal Postoperative Pain Management
        • 7.2.1.4. Others
      • 7.2.2. Global Post Operative Pain Management by: Distribution Channel (Value)
        • 7.2.2.1. Hospital Pharmacies
        • 7.2.2.2. Retail Pharmacies
        • 7.2.2.3. Drug Stores
        • 7.2.2.4. Others
      • 7.2.3. Global Post Operative Pain Management Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Post Operative Pain Management: by Route of Administration(USD Million)
  • Table 2. Post Operative Pain Management Injectable Postoperative Pain Management , by Region USD Million (2016-2021)
  • Table 3. Post Operative Pain Management Oral Postoperative Pain Management , by Region USD Million (2016-2021)
  • Table 4. Post Operative Pain Management Transdermal Postoperative Pain Management , by Region USD Million (2016-2021)
  • Table 5. Post Operative Pain Management Others , by Region USD Million (2016-2021)
  • Table 6. Post Operative Pain Management: by Distribution Channel(USD Million)
  • Table 7. Post Operative Pain Management Hospital Pharmacies , by Region USD Million (2016-2021)
  • Table 8. Post Operative Pain Management Retail Pharmacies , by Region USD Million (2016-2021)
  • Table 9. Post Operative Pain Management Drug Stores , by Region USD Million (2016-2021)
  • Table 10. Post Operative Pain Management Others , by Region USD Million (2016-2021)
  • Table 11. South America Post Operative Pain Management, by Country USD Million (2016-2021)
  • Table 12. South America Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 13. South America Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 14. South America Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 15. Brazil Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 16. Brazil Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 17. Brazil Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 18. Argentina Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 19. Argentina Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 20. Argentina Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 21. Rest of South America Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 22. Rest of South America Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 23. Rest of South America Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 24. Asia Pacific Post Operative Pain Management, by Country USD Million (2016-2021)
  • Table 25. Asia Pacific Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 26. Asia Pacific Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 27. Asia Pacific Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 28. China Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 29. China Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 30. China Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 31. Japan Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 32. Japan Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 33. Japan Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 34. India Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 35. India Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 36. India Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 37. South Korea Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 38. South Korea Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 39. South Korea Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 40. Taiwan Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 41. Taiwan Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 42. Taiwan Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 43. Australia Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 44. Australia Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 45. Australia Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 46. Rest of Asia-Pacific Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 47. Rest of Asia-Pacific Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 48. Rest of Asia-Pacific Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 49. Europe Post Operative Pain Management, by Country USD Million (2016-2021)
  • Table 50. Europe Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 51. Europe Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 52. Europe Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 53. Germany Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 54. Germany Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 55. Germany Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 56. France Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 57. France Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 58. France Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 59. Italy Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 60. Italy Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 61. Italy Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 62. United Kingdom Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 63. United Kingdom Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 64. United Kingdom Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 65. Netherlands Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 66. Netherlands Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 67. Netherlands Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 68. Rest of Europe Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 69. Rest of Europe Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 70. Rest of Europe Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 71. MEA Post Operative Pain Management, by Country USD Million (2016-2021)
  • Table 72. MEA Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 73. MEA Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 74. MEA Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 75. Middle East Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 76. Middle East Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 77. Middle East Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 78. Africa Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 79. Africa Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 80. Africa Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 81. North America Post Operative Pain Management, by Country USD Million (2016-2021)
  • Table 82. North America Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 83. North America Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 84. North America Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 85. United States Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 86. United States Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 87. United States Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 88. Canada Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 89. Canada Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 90. Canada Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 91. Mexico Post Operative Pain Management, by Route of Administration USD Million (2016-2021)
  • Table 92. Mexico Post Operative Pain Management, by Distribution Channel USD Million (2016-2021)
  • Table 93. Mexico Post Operative Pain Management, by Treatment USD Million (2016-2021)
  • Table 94. Company Basic Information, Sales Area and Its Competitors
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Post Operative Pain Management: by Route of Administration(USD Million)
  • Table 105. Post Operative Pain Management Injectable Postoperative Pain Management , by Region USD Million (2022-2027)
  • Table 106. Post Operative Pain Management Oral Postoperative Pain Management , by Region USD Million (2022-2027)
  • Table 107. Post Operative Pain Management Transdermal Postoperative Pain Management , by Region USD Million (2022-2027)
  • Table 108. Post Operative Pain Management Others , by Region USD Million (2022-2027)
  • Table 109. Post Operative Pain Management: by Distribution Channel(USD Million)
  • Table 110. Post Operative Pain Management Hospital Pharmacies , by Region USD Million (2022-2027)
  • Table 111. Post Operative Pain Management Retail Pharmacies , by Region USD Million (2022-2027)
  • Table 112. Post Operative Pain Management Drug Stores , by Region USD Million (2022-2027)
  • Table 113. Post Operative Pain Management Others , by Region USD Million (2022-2027)
  • Table 114. South America Post Operative Pain Management, by Country USD Million (2022-2027)
  • Table 115. South America Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 116. South America Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 117. South America Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 118. Brazil Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 119. Brazil Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 120. Brazil Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 121. Argentina Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 122. Argentina Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 123. Argentina Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 124. Rest of South America Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 125. Rest of South America Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 126. Rest of South America Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 127. Asia Pacific Post Operative Pain Management, by Country USD Million (2022-2027)
  • Table 128. Asia Pacific Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 129. Asia Pacific Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 130. Asia Pacific Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 131. China Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 132. China Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 133. China Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 134. Japan Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 135. Japan Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 136. Japan Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 137. India Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 138. India Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 139. India Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 140. South Korea Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 141. South Korea Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 142. South Korea Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 143. Taiwan Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 144. Taiwan Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 145. Taiwan Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 146. Australia Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 147. Australia Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 148. Australia Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 149. Rest of Asia-Pacific Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 150. Rest of Asia-Pacific Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 151. Rest of Asia-Pacific Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 152. Europe Post Operative Pain Management, by Country USD Million (2022-2027)
  • Table 153. Europe Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 154. Europe Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 155. Europe Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 156. Germany Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 157. Germany Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 158. Germany Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 159. France Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 160. France Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 161. France Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 162. Italy Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 163. Italy Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 164. Italy Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 165. United Kingdom Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 166. United Kingdom Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 167. United Kingdom Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 168. Netherlands Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 169. Netherlands Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 170. Netherlands Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 171. Rest of Europe Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 172. Rest of Europe Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 173. Rest of Europe Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 174. MEA Post Operative Pain Management, by Country USD Million (2022-2027)
  • Table 175. MEA Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 176. MEA Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 177. MEA Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 178. Middle East Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 179. Middle East Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 180. Middle East Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 181. Africa Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 182. Africa Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 183. Africa Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 184. North America Post Operative Pain Management, by Country USD Million (2022-2027)
  • Table 185. North America Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 186. North America Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 187. North America Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 188. United States Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 189. United States Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 190. United States Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 191. Canada Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 192. Canada Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 193. Canada Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 194. Mexico Post Operative Pain Management, by Route of Administration USD Million (2022-2027)
  • Table 195. Mexico Post Operative Pain Management, by Distribution Channel USD Million (2022-2027)
  • Table 196. Mexico Post Operative Pain Management, by Treatment USD Million (2022-2027)
  • Table 197. Research Programs/Design for This Report
  • Table 198. Key Data Information from Secondary Sources
  • Table 199. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Post Operative Pain Management: by Route of Administration USD Million (2016-2021)
  • Figure 5. Global Post Operative Pain Management: by Distribution Channel USD Million (2016-2021)
  • Figure 6. South America Post Operative Pain Management Share (%), by Country
  • Figure 7. Asia Pacific Post Operative Pain Management Share (%), by Country
  • Figure 8. Europe Post Operative Pain Management Share (%), by Country
  • Figure 9. MEA Post Operative Pain Management Share (%), by Country
  • Figure 10. North America Post Operative Pain Management Share (%), by Country
  • Figure 11. Global Post Operative Pain Management share by Players 2021 (%)
  • Figure 12. Global Post Operative Pain Management share by Players (Top 3) 2021(%)
  • Figure 13. Global Post Operative Pain Management share by Players (Top 5) 2021(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Teva Pharmaceutical Industries Ltd., (Israel) Revenue, Net Income and Gross profit
  • Figure 16. Teva Pharmaceutical Industries Ltd., (Israel) Revenue: by Geography 2021
  • Figure 17. Novartis AG, (Switzerland) Revenue, Net Income and Gross profit
  • Figure 18. Novartis AG, (Switzerland) Revenue: by Geography 2021
  • Figure 19. Allergan plc, (Ireland) Revenue, Net Income and Gross profit
  • Figure 20. Allergan plc, (Ireland) Revenue: by Geography 2021
  • Figure 21. Mylan N.V., (United States) Revenue, Net Income and Gross profit
  • Figure 22. Mylan N.V., (United States) Revenue: by Geography 2021
  • Figure 23. Pfizer Inc., (United States) Revenue, Net Income and Gross profit
  • Figure 24. Pfizer Inc., (United States) Revenue: by Geography 2021
  • Figure 25. Purdue Pharma L.P, (United States) Revenue, Net Income and Gross profit
  • Figure 26. Purdue Pharma L.P, (United States) Revenue: by Geography 2021
  • Figure 27. Janssen Pharmaceuticals, Inc., (Belgium) Revenue, Net Income and Gross profit
  • Figure 28. Janssen Pharmaceuticals, Inc., (Belgium) Revenue: by Geography 2021
  • Figure 29. Endo International plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 30. Endo International plc (Ireland) Revenue: by Geography 2021
  • Figure 31. Pacira Pharmaceuticals Inc., (United States) Revenue, Net Income and Gross profit
  • Figure 32. Pacira Pharmaceuticals Inc., (United States) Revenue: by Geography 2021
  • Figure 33. GlaxoSmithKline Plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. GlaxoSmithKline Plc. (United Kingdom) Revenue: by Geography 2021
  • Figure 35. Global Post Operative Pain Management: by Route of Administration USD Million (2022-2027)
  • Figure 36. Global Post Operative Pain Management: by Distribution Channel USD Million (2022-2027)
  • Figure 37. South America Post Operative Pain Management Share (%), by Country
  • Figure 38. Asia Pacific Post Operative Pain Management Share (%), by Country
  • Figure 39. Europe Post Operative Pain Management Share (%), by Country
  • Figure 40. MEA Post Operative Pain Management Share (%), by Country
  • Figure 41. North America Post Operative Pain Management Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Teva Pharmaceutical Industries Ltd., (Israel)
  • Novartis AG, (Switzerland)
  • Allergan plc, (Ireland)
  • Mylan N.V., (United States)
  • Pfizer Inc., (United States)
  • Purdue Pharma L.P, (United States)
  • Janssen Pharmaceuticals, Inc., (Belgium)
  • Endo International plc (Ireland)
  • Pacira Pharmaceuticals Inc., (United States)
  • GlaxoSmithKline Plc. (United Kingdom)
Additional players considered in the study are as follows:
Egalet Corporation (United States)
Select User Access Type

Key Highlights of Report


Mar 2022 216 Pages 53 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Post Operative Pain Management Market Quantitative research analysis
Global Post Operative Pain Management Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Teva Pharmaceutical Industries Ltd., (Israel), Novartis AG, (Switzerland), Allergan plc, (Ireland), Mylan N.V., (United States), Pfizer Inc., (United States), Purdue Pharma L.P, (United States), Janssen Pharmaceuticals, Inc., (Belgium), Endo International plc (Ireland), Pacira Pharmaceuticals Inc., (United States) and GlaxoSmithKline Plc. (United Kingdom) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
Analysts at AMA estimates Post Operative Pain Management Market to reach USD Million by 2027.

Know More About Global Post Operative Pain Management Market Report?

Have a Query? Click Here

Other Related Reports

Virtual Fitness App Comprehensive Study by Type (Pay by course, Pay by time, Free course), Application (Millennials, Gen Z, Gen X, Baby Boomers), Training (Yoga, HIIT, Pilates, Barre, Others), Device...
$ 3800
Optical Lens Shape Tracers Comprehensive Study by Application (Eyeglass Lens, Microscope Lens, Camera Lens, Others), Product Type (Automatic, Manual), End-user (Hospitals, Clinics, Eye-care center, O...
$ 3800
Retinal Disorders Therapy- Comprehensive Study by Disease Generation (Macular Degeneration, Dry Macular Degeneration, Wet Macular Degeneration, Diabetic Retinopathy, Others), Distribution Channel (H...
$ 3800
Laser Cancer Therapy Comprehensive Study by Application (Dermatology and Aesthetics, Dental, Ophthalmology, Cardiovascular, Others), End-users (Hospitals, Specialty Clinics, Cancer and Radiation Ther...
$ 3800
Smart Vision Aids Comprehensive Study by Type (Audio-visual Conversion, Implantable BMI, Non-implantable BMI), Application (Central Vision Loss, Blurry Vision, Blind Spot, Others), Product Type (Smar...
$ 3800
Metaverse in Healthcare Comprehensive Study by Technology (Virtual Reality, Augmented Reality, Mixed Reality, Artificial Intelligence), Device (Virtual Reality Headsets, Augmented Reality Devices, Mi...
$ 3800